Hendrix MJC - Search Results

1

The Stem Cell Phenotype of Aggressive Breast Cancer Cells.

Margaryan NV, Hazard-Jenkins H, Salkeni MA, Smolkin MB, Coad JA, Wen S, Seftor EA, Seftor REB, Hendrix MJC. Margaryan NV, et al. Among authors: hendrix mjc. Cancers (Basel). 2019 Mar 8;11(3):340. doi: 10.3390/cancers11030340. Cancers (Basel). 2019. PMID: 30857267 Free PMC article.

2

Targeting the Stem Cell Properties of Adult Breast Cancer Cells: Using Combinatorial Strategies to Overcome Drug Resistance.

Margaryan NV, Seftor EA, Seftor REB, Hendrix MJC. Margaryan NV, et al. Among authors: hendrix mjc. Curr Mol Biol Rep. 2017 Sep;3(3):159-164. doi: 10.1007/s40610-017-0067-5. Epub 2017 Jul 10. Curr Mol Biol Rep. 2017. PMID: 29152453 Free PMC article.

3

Heterogeneity of Melanoma with Stem Cell Properties.

Seftor EA, Margaryan NV, Seftor REB, Hendrix MJC. Seftor EA, et al. Among authors: hendrix mjc. Adv Exp Med Biol. 2019;1139:105-114. doi: 10.1007/978-3-030-14366-4_6. Adv Exp Med Biol. 2019. PMID: 31134497 Review.

4

Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells.

Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE, Hendrix MJ. Postovit LM, et al. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4329-34. doi: 10.1073/pnas.0800467105. Epub 2008 Mar 11. Proc Natl Acad Sci U S A. 2008. PMID: 18334633 Free PMC article.

5

Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells.

Hendrix MJ, Kandela I, Mazar AP, Seftor EA, Seftor RE, Margaryan NV, Strizzi L, Murphy GF, Long GV, Scolyer RA. Hendrix MJ, et al. Lab Invest. 2017 Feb;97(2):176-186. doi: 10.1038/labinvest.2016.107. Epub 2016 Oct 24. Lab Invest. 2017. PMID: 27775691 Free article.

6

Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells.

Hendrix MJ, Seftor EA, Kirschmann DA, Seftor RE. Hendrix MJ, et al. Breast Cancer Res. 2000;2(6):417-22. doi: 10.1186/bcr88. Epub 2000 Aug 11. Breast Cancer Res. 2000. PMID: 11250735 Free PMC article. Review.

7

Remodeling of the microenvironment by aggressive melanoma tumor cells.

Hendrix MJ, Seftor EA, Kirschmann DA, Quaranta V, Seftor RE. Hendrix MJ, et al. Ann N Y Acad Sci. 2003 May;995:151-61. doi: 10.1111/j.1749-6632.2003.tb03218.x. Ann N Y Acad Sci. 2003. PMID: 12814947 Review.

8

Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells.

Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, Amir S, Seftor RE, Seftor EA, Hendrix MJ. Odero-Marah VA, et al. Cancer Biol Ther. 2003 Jul-Aug;2(4):398-403. doi: 10.4161/cbt.2.4.471. Cancer Biol Ther. 2003. PMID: 14508113

9

Influence of the microenvironment on melanoma cell fate determination and phenotype.

Postovit LM, Seftor EA, Seftor RE, Hendrix MJ. Postovit LM, et al. Cancer Res. 2006 Aug 15;66(16):7833-6. doi: 10.1158/0008-5472.CAN-06-0731. Cancer Res. 2006. PMID: 16912153 Review.

10

Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression.

Strizzi L, Postovit LM, Margaryan NV, Seftor EA, Abbott DE, Seftor RE, Salomon DS, Hendrix MJ. Strizzi L, et al. Breast Dis. 2008;29:91-103. doi: 10.3233/bd-2008-29110. Breast Dis. 2008. PMID: 19029628 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page